April 30, 2002
1 min read
Save

Antibiotic treatment of IOLs can reduce bacterial adherence, study suggests

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

HYDERABAD, India — The incidence of post-cataract endophthalmitis might be reduced by treating the IOL with an antibacterial agent before implantation, a small study here suggests. Surgeons who treat IOLs with vancomycin might be able to reduce the levels of bacterial adherence to PMMA IOLs, the study authors said.

Taraprasad Das, MD, and colleagues here with the Endophthalmitis Research Group soaked 12 PMMA IOLs in solutions of Staphylococcus epidermidis in variable loads. The lenses were rinsed or rinsed and vortexed and then cultured. A second set of 12 IOLs were treated with vancomycin (10 mg/mL), randomized to before and after treatment with S. epidermidis.

The researchers found the IOLs treated with vancomycin had less S. epidermidis adherence than lenses not treated with the antibacterial agent.

The study can be found in the April issue of Journal of Cataract & Refractive Surgery.